Calculated as the aggregate maximum value of Shares being purchased. The fee of $$4,113.75 was paid in connection with the filing
of the Schedule TO-I by Morgan Stanley Private Markets and Alternatives Fund - Balanced (File No. 005-95504) on May 15, 2026 (the “Schedule
TO”). This is the final amendment to the Schedule TO and is being filed to report the results of the offer.
[1]
Calculated as the aggregate maximum value of Shares being purchased. The fee of $$4,113.75 was paid in connection with the filing
of the Schedule TO-I by Morgan Stanley Private Markets and Alternatives Fund - Balanced (File No. 005-95504) on May 15, 2026 (the “Schedule
TO”). This is the final amendment to the Schedule TO and is being filed to report the results of the offer.